DK1744736T3 - Fremgangsmåde til behandling af problemer med tørre øjne og uveitis - Google Patents

Fremgangsmåde til behandling af problemer med tørre øjne og uveitis

Info

Publication number
DK1744736T3
DK1744736T3 DK05751168.5T DK05751168T DK1744736T3 DK 1744736 T3 DK1744736 T3 DK 1744736T3 DK 05751168 T DK05751168 T DK 05751168T DK 1744736 T3 DK1744736 T3 DK 1744736T3
Authority
DK
Denmark
Prior art keywords
uveitis
procedure
dry eyes
treating problems
treating
Prior art date
Application number
DK05751168.5T
Other languages
Danish (da)
English (en)
Inventor
Peter G Klimko
Mark R Hellberg
Daniel A Gamache
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of DK1744736T3 publication Critical patent/DK1744736T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
DK05751168.5T 2004-05-14 2005-05-12 Fremgangsmåde til behandling af problemer med tørre øjne og uveitis DK1744736T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57116204P 2004-05-14 2004-05-14
PCT/US2005/016646 WO2005112905A1 (en) 2004-05-14 2005-05-12 Method of treating dry eye disorders and uveitis

Publications (1)

Publication Number Publication Date
DK1744736T3 true DK1744736T3 (da) 2010-02-15

Family

ID=34968761

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05751168.5T DK1744736T3 (da) 2004-05-14 2005-05-12 Fremgangsmåde til behandling af problemer med tørre øjne og uveitis

Country Status (19)

Country Link
US (1) US20050256189A1 (enExample)
EP (1) EP1744736B1 (enExample)
JP (2) JP4993299B2 (enExample)
KR (1) KR101170885B1 (enExample)
CN (1) CN100522147C (enExample)
AT (1) ATE448779T1 (enExample)
AU (1) AU2005244839B2 (enExample)
BR (1) BRPI0511125A (enExample)
CA (1) CA2563659C (enExample)
CY (1) CY1109666T1 (enExample)
DE (1) DE602005017762D1 (enExample)
DK (1) DK1744736T3 (enExample)
ES (1) ES2334368T3 (enExample)
MX (1) MXPA06013170A (enExample)
PL (1) PL1744736T3 (enExample)
PT (1) PT1744736E (enExample)
SI (1) SI1744736T1 (enExample)
WO (1) WO2005112905A1 (enExample)
ZA (1) ZA200609220B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005304733B2 (en) 2004-11-09 2011-04-07 Alcon, Inc. 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses
US7687539B1 (en) 2005-11-07 2010-03-30 Alcon Research, Ltd. Method of treating ocular allergy
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength
WO2011096941A1 (en) * 2010-02-08 2011-08-11 Alcon Research, Ltd. Method of treating ocular allergy
JP2013521230A (ja) * 2010-02-25 2013-06-10 アルコン リサーチ， リミテッド 角膜創傷治癒を促進する方法
WO2012112873A2 (en) 2011-02-18 2012-08-23 3M Innovative Properties Company Flexible light emitting semiconductor device
KR102593305B1 (ko) * 2020-11-25 2023-10-25 서울대학교 산학협력단 인공지능 기반 의류 사이즈 추천 방법 및 시스템

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4131651A (en) * 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4370325A (en) * 1979-03-30 1983-01-25 Dermik Laboratories Pharmaceutical compositions and method of treatment
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4744980A (en) * 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4818537A (en) * 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US5278151A (en) * 1987-04-02 1994-01-11 Ocular Research Of Boston, Inc. Dry eye treatment solution
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
ZA912797B (en) * 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
EP0459148B1 (en) * 1990-05-29 1996-01-03 Ocular Research Of Boston Inc. Dry eye treatment composition
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
US5958912A (en) * 1992-04-21 1999-09-28 The Schepens Eye Research Institute, Inc. Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β
US5290572A (en) * 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
US5441951A (en) * 1994-06-15 1995-08-15 Brigham & Women's Hospital Lipoxin compounds
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
WO1997020578A1 (en) * 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
EP1237549B1 (en) * 1999-11-09 2004-02-04 Alcon, Inc Lipoxin a4 and analogues for the treatment of dry eye

Also Published As

Publication number Publication date
KR101170885B1 (ko) 2012-08-07
WO2005112905A1 (en) 2005-12-01
ES2334368T3 (es) 2010-03-09
JP4993299B2 (ja) 2012-08-08
CY1109666T1 (el) 2014-08-13
AU2005244839A2 (en) 2005-12-01
EP1744736B1 (en) 2009-11-18
CA2563659A1 (en) 2005-12-01
PL1744736T3 (pl) 2010-03-31
EP1744736A1 (en) 2007-01-24
JP2012107053A (ja) 2012-06-07
CN1953740A (zh) 2007-04-25
AU2005244839B2 (en) 2009-12-24
MXPA06013170A (es) 2007-02-13
US20050256189A1 (en) 2005-11-17
DE602005017762D1 (de) 2009-12-31
ATE448779T1 (de) 2009-12-15
KR20070011582A (ko) 2007-01-24
CN100522147C (zh) 2009-08-05
JP2007537282A (ja) 2007-12-20
PT1744736E (pt) 2010-01-05
ZA200609220B (en) 2009-02-25
SI1744736T1 (sl) 2010-01-29
AU2005244839A1 (en) 2005-12-01
CA2563659C (en) 2012-03-20
BRPI0511125A (pt) 2007-11-27

Similar Documents

Publication Publication Date Title
NL301145I2 (nl) Tirbanibulin
EA201071245A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера и связанных нарушений посредством модулирования реакции клеток на стресс
CY1118768T1 (el) Ετεροκυκλικοι ρυθμιστες μεταφορεων κασετας συνδεσης atp
NO20074943L (no) Roflumilast for behandlingen av diabetes mellitus
EA202092490A1 (ru) Модуляторы метилмодифицирующих ферментов, композиции и их применения
DK1615952T3 (da) Fremgangsmåder til behandling af betændelsestilstande med specifikke, til humant angiopoietin-2-bindende midler
DK1509121T3 (da) Okulærvisningsapparat til behandling af øjenlidelser
DK2026803T3 (da) Sammensætninger af R(+) og S(-) pramipexol og fremgangsmåder til anvendelse heraf
DK2023918T3 (da) Cyclosporiner til behandlingen og forebyggelse af okulære lidelser
DK1888094T3 (da) Amylin og amylinagonister til behandling af psykiatriske sygdomme og forstyrrelser
EA201000016A1 (ru) Способы и композиции для лечения рака, опухолей и нарушений, связанных с опухолями
CY1107531T1 (el) Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου
DK1237549T3 (da) Lipoxin A4 og dets analoger til behandling af törre öjne
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
TW200509896A (en) Analeptic and drug combinations
DK1919466T3 (da) Formuleringer til behandling af lipoprotein-abnormiteter omfattende et statin og et methylnicotinamidderivat
NO20044530L (no) Fremgangsmate for behandling av kognitive forstyrrelser
CY1107562T1 (el) Χρηση των ν-(2-αρυλ-προπιονυλ)-σουκλφοναμιδιων για τη θepαπεια του τραυματος του νωτιαιου μυελου
TW200744567A (en) Phenylethylamine analogs and their use for treating glaucoma
MX394960B (es) Inhibidor de esterasa c1 conjugado y sus usos.
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
DK1853232T3 (da) Stabil krystallin form af bifeprunox mesylat, doseringsformer deraf og fremgangsmåder for deres anvendelse
DK1771415T3 (da) 2-(1H-indolylsulfanyl)-arylaminderivater til anvendelse i behandlingen af affektive sygdomme, smerte, ADHD og stressinkontinens
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
HRP20090513T1 (hr) S-mirtazapin, namijenjen liječenju napadaja vrućine